Analgesie und Sedierung bei Kindern

(Analgo-)Sedierungsprotokolle helfen, Kinder optimal schmerztherapeutisch zu versorgen. Im Vordergrund stehen die Reduktion der Schmerzreize im klinischen Alltag, die frühzeitige analgetische Therapie mit peripher wirkenden Schmerzmedikamenten oder in Kombination mit Opioidanalgetika nach dem Leitsatz „frühzeitig, ausreichend stark behandeln“. Die medikamentöse Therapie sollte immer in ein protokolliertes, multimodales (Schmerz-)Sedierungskonzept eingebettet sein, das auch ein Ausschleichen der Behandlung beinhaltet.

Schlüsselwörter

Schmerzmessung - Schmerztherapie - Sedierung - Entzug - pädiatrisches Delir

• Literatur

• 1 Raja SN, Carr DB, Finnerup NB. et al. The Revised IASP definition of pain: concepts, challenges, and compromises. Pain 2020; 161: 1976-1982
• 2 Egbuta C, Mason KP. Current state of analgesia and sedation in the pediatric intensive care unit. J Clin Med 2021; 10: 1847
• 3 AWMF. S3-Leitlinie „Analgesie, Sedierung und Delirmanagement in der Intensivmedizin (DAS-Leitlinie)“ Registernummer 001–012. 2021 Accessed March 21, 2022 at: https://www.awmf.org/leitlinien/detail/ll/001–012.html
• 4 Friedrichsdorf SJ, Goubert L. Pediatric pain treatment and prevention for hospitalized children. Pain Rep 2020; 5: e804
• 5 Guerra GG, Robertson CMT, Altonet GY. et al. Neurotoxicity of sedative and analgesia drugs in young infants with congenital heart disease: 4 year follow up. Pediatr Anesthesia 2013; 24: 257-265
• 6 Rosenberg L, Traube C. Sedation strategies in children with pediatric acute respiratory distress syndrome (PARDS). Ann Transl Med 2019; 7: 509
• 7 Turner AD, Sullivan T, Drury K. et al. Cognitive dysfunction after analgesia and sedation: out of the operating room and into the pediatric intensive care unit. Front Behav Neurosci 2021; 15: 713668
• 8 Morone NE, Weiner DK. Pain as the fifth vital sign: exposing the vital need for pain education. Clin Ther 2013; 35: 1728-1732
• 9 Harris J, Ramelet A-S, van Dijk M. et al. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med 2016; 42: 972-986
• 10 Patel AK, Trujillo-Rivera E, Faruqe F. et al. Sedation, analgesia and neuromuscular blockade: an assessment of practices from 2009–2016 in a national sample of 66,443 pediatric patients cared for in the intensive care unit. Pediatr Crit Care Med 2020; 21: e599-e609
• 11 Daverio M, von Borell F, Ramelet A-S. et al. Pain and sedation management and monitoring in pediatric intensive care units across Europe: an ESPNIC survey. Crit Care 2022; 26: 88
• 12 Comfort Assessment. Comfort behavior scale. Accessed March 19, 2022 at: https://www.comfortassessment.nl/web/index.php/instruments/comfort
• 13 Malviya S, Voepel-Lewis T, Burke C. et al. The revised FLACC observational pain tool: improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth 2006; 16: 258-265
• 14 Franck LS. Withdrawal Assessment Tool. Accessed March 19, 2022 at: https://www.mdcalc.com/withdrawal-assessment-tool-wat-1-pediatric-withdrawal
• 15 Comfort Assessment. SOS-PD-Skala (Sophia Observation withdrawal Symptoms-scale and Pediatric Delirium). Accessed March 19, 2022 at: https://www.comfortassessment.nl/web/index.php/instruments/sos-pediatric-delirium-sos-pd
• 16 Franck LS, Harris SK, Soetenga DJ. et al. The withdrawal assessment tool – version 1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients. Pediatr Crit Care Med 2008; 9: 573-580
• 17 Smith HAB, Besunder JB, Betters KA. et al. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically Ill pediatric patients with consideration of the ICU environment and early mobility. Pediatr Crit Care Med 2020; 23: e74-e110
• 18 Yıldız İU, Yıldırım Ç, Özhasenekler A. et al. Effectiveness of lidocaine spray on radial arterial puncture pain: a randomized double-blind placebo controlled trial. Am J Emerg Med 2021; 50: 724-728
• 19 Baarslag MA, Allegaert K, Van Den Anker JN. et al. Paracetamol and morphine for infant and neonatal pain; still a long way to go?. Expert Rev Clin Pharmacol 2017; 10: 111-126
• 20 Seki H, Ideno S, Ishihara T. et al. Postoperative pain management in patients undergoing posterior spinal fusion for adolescent idiopathic scoliosis: a narrative review. Scoliosis Spinal Disord 2018; 13: 17
• 21 Estkowsky LM, Morris JL, Sinclair EA. Characterization of dexmedetomidine dosing and safety in neonates and infants. J Pediatr Pharmacol Ther 2015; 20: 112-118
• 22 Sperotto F, Mondardini MC, Dell’Oste C. et al. Efficacy and safety of dexmedetomidine for prolonged sedation in the PICU: a prospective multicenter study (PROSDEX). Pediatr Crit Care Med 2020; 21: 625-636
• 23 Mahmoud M, Barbi E, Mason KP. Dexmedetomidine: what’s new for pediatrics? A narrative review. J Clin Med 2020; 9: 2724
• 24 Ziesenitz VC, Vaughns JD, Koch G. et al. Pharmacokinetics of fentanyl and its derivatives in children: a comprehensive review. Clin Pharmacokinet 2018; 57: 125-149
• 25 Welzing L, Link F, Junghaenel S. et al. Remifentanil induced tolerance, withdrawal or hyperalgesia in infants: a randomised controlled trial. RAPIP trial: remifentanil-based analgesia and sedation of paediatric intensiv care patients. Neonatology 2013; 104: 34-41
• 26 Anand KJS, Willson DF, Berger J. et al. Tolerance and withdrawal from prolonged opioid use in critical ill children. Pediatrics 2010; 125: e1208-e1225
• 27 Best KM, Wypij D, Asaro LA. et al. Patient, process, and system predictors of iatrogenic withdrawal syndrome in critically Ill children. Crit Care Med 2017; 45: e7-e15
• 28 Vet NJ, de Wildt SN, Verlaat CWM. et al. A randomized controlled trial of daily sedation interruption in critically ill children. Intensive Care Med 2016; 42: 233-244
• 29 Joyce C, Witcher R, Herrup E. et al. Evaluation of the safety of quetiapine and critically ill children. A retrospective review. J Child Adolesc Psychopharmacol 2015; 25: 666-670
• 30 Sloof VD, van den Dungen DK, van Beusekom BS. et al. Monitoring Haloperidol Plasma Concentration and Associated Adverse Events in Critically Ill Children With Delirium: First Results of a Clinical Protocol Aimed to Monitor Efficacy and Safety. Pediatr Crit Care Med 2018; 19: e112-e119
• 31 Cronin MT, Di Gennaro JL, Watson RS. et al. Haloperidol and quetiapine for the treatment of ICU-associated delirium in a tertiary pediatric ICU: a propensity score-matched cohort study. Paediatr Drugs 2021; 23: 159-169